RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 Optimizing Therapy for Acute Coronary Syndrome
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 10
SP 27
OP 30
DO 10.1177/1559897715591130
UL http://mdc.sagepub.com/content/15/10/27.abstract
AB Percutaneous coronary intervention is the primary treatment for patients with acute coronary syndrome. Selective use of manual thrombectomy may be an effective option. P2Y12 inhibitors are a treatment of choice in patients with STEMI. Bivalirudin reduces adverse cardiac events and is associated with reduced bleeding. When percutaneous coronary intervention is delayed in patients with STEMI, fibrinolytic therapy should be administered.